DEBUG: PAGE=domain, TITLE=Life Sciences,ID=1609,TEMPLATE=subprogram
toggle expanded view
programcode = HAILSC
programid = 334
database = f
alerts = t
neat = t
vendors = t
forecasting = f
confidence = f
definitions = f

Search within: Life Sciences:

Access our analyst expertise:

Only NelsonHall clients who are logged in have access to our analysts and advisors for their expert advice and opinion.

To find out more about how NelsonHall's analysts and sourcing advisors can assist you with your strategy and engagements, please contact our sales department here.

Subscribe to blogs & alerts:

manage email alerts using the form below, in order to be notified via email whenever we publish new content:

has Database = f has Confidence = f -- IGNORED

Tech Mahindra - Pharmaceuticals / Life Sciences Operational Transformation

Vendor Analysis

by Alisa Samoylova

published on Nov 24, 2021

Access to this report is restricted to logged in clients with access. Login to get full access

Report Overview:

This NelsonHall vendor assessment analyzes Tech Mahindra's offerings and capabilities in Pharmaceuticals / Life Sciences Operational Transformation

Who is this Report for:

NelsonHall’s pharmaceuticals / life sciences operational transformation profile on Tech Mahindra is a comprehensive assessment of Tech Mahindra’s offerings and capabilities, designed for:

  • Sourcing managers monitoring the capabilities of existing suppliers of pharmaceuticals / life sciences operational transformation services and identifying vendor suitability for operational transformation services RFPs
  • Vendor marketing, sales, and business managers looking to benchmark themselves against their peers
  • Financial analysts and investors specializing in the pharmaceuticals / life sciences services sector.

Scope of this Report:

The report provides a comprehensive and objective analysis of Tech Mahindra’s pharmaceuticals / life sciences operational transformation offerings and capabilities, and market and financial strengths, including:

  • Identification of the company’s strategy, emphasis, and new developments
  • Analysis of the company’s strengths, weaknesses, and outlook
  • Revenue estimates
  • Analysis of the profile of the company’s customer base, including the company’s targeting strategy and examples of current contracts
  • Analysis of the company’s offerings and key service components
  • Analysis of the company’s delivery organization, including the location of delivery locations.

Key Findings & Highlights:

Tech Mahindra has a dedicated healthcare and life sciences practice. The practice relies on wider Tech Mahindra's IT expertise to build solutions. Key offerings for pharmaceutical/life sciences operational transformation clients currently include:

  • Digital marketing, including post-market communication and campaign management
  • Pharmaceutical master data management
  • Medical affairs, including literature and regulatory reviews
  • Safety services, including adverse event reporting
  • Artwork and pack management
  • Patient assistance program and therapy adherence
  • Service desk
  • Medical image annotation
  • Supply chain management
  • Automation in pharma back-office operations.

In March 2021, Tech Mahindra has acquired a majority stake in Perigord Asset Holdings, a digital workflow, artworks, labeling, and BPO services firm. Tech Mahindra looks to leverage Perigord to improve artwork and pack management delivery and build presence in Ireland, Germany, the U.S., and India.

Login to get full access: